Motor decline in clinically presymptomatic spinocerebellar ataxia type 2 gene carriers

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Velázquez Perez, Luis ^a   Díaz, Rosalinda ^b   Pérez González, Ruth ^a   Canales, Nalia ^a   Rodríguez Labrada, Roberto ^a   Medrano, Jacquelín ^a   Sánchez, Gilberto ^a   Almaguer Mederos, Luis ^a   Torres, Cira ^a   Fernandez Ruiz, Juan ^b,c  

^a Centro para la Investigacion y Rehabilitacion de las Ataxias Hereditarias Cuba   (Cuba)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSIDAD VERACRUZANA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; SPINOCEREBELLAR ATAXIA TYPE 2 PROTEIN; UNCLASSIFIED DRUG; NERVE PROTEIN; SCA2 PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; SPINOCEREBELLAR DEGENERATION; VISUOMOTOR COORDINATION; VOLUNTEER; CASE CONTROL STUDY; GENETICS; MIDDLE AGED; ONSET AGE; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME; TRINUCLEOTIDE REPEAT; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MOTOR SKILLS; NERVE TISSUE PROTEINS; SPINOCEREBELLAR ATAXIAS; TIME FACTORS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 65549135544     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005398     Document Type: Article

References (30)

1. Velazquez-Perez L, Seifried C, Santos-Falcon N, Abele M, Ziemann U, et al. (2004) Saccade velocity is controlled by polyglutamine size in spinocerebellar ataxia 2. Ann Neurol 56: 444-447.
2. Fernandez-Ruiz J, Diaz R, Hall-Haro C, Vergara P, Fiorentini A, et al. (2003) Olfactory dysfunction in hereditary ataxia and basal ganglia disorders. Neuroreport 14: 1339-1341.
3. Velazquez-Perez L, Fernandez-Ruiz J, Diaz R, Gonzalez RP, Ochoa NC, et al. (2006) Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases. J Neurol 253: 1165-1169.
4. Durr A, Smadja D, Cancel G, Lezin A, Stevanin G, et al. (1995) Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain 118 (Pt 6): 1573-1581.
5. Orozco G, Estrada R, Perry TL, Arana J, Fernandez R, et al. (1989) Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findings. J Neurol Sci 93: 37-50.
6. Pang JT, Giunti P, Chamberlain S, An SF, Vitaliani R, et al. (2002) Neuronal intranuclear inclusions in SCA2: a genetic, morphological and immunohistochemical study of two cases. Brain 125: 656-663.
7. Geschwind DH, Perlman S, Figueroa CP, Treiman LJ, Pulst SM (1997) The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet 60: 842-850.
8. Schols L, Bauer P, Schmidt T, Schulte T, Riess O (2004) Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 3: 291-304.
9. Pulst SM, Nechiporuk A, Nechiporuk T, Gispert S, Chen XN, et al. (1996) Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 14: 269-276.
10. Fox NC, Warrington EK, Seiffer AL, Agnew SK, Rossor MN (1998) Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study. Brain 121 (Pt 9): 1631-1639.
11. Blekher TM, Yee RD, Kirkwood SC, Hake AM, Stout JC, et al. (2004) Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington's disease. Vision Res 44: 2729-2736.
12. Christova P, Anderson JH, Gomez CM (2008) Impaired eye movements in presymptomatic spinocerebellar ataxia type 6. Arch Neurol 65: 530-536.
13. Siemers E, Foroud T, Bill DJ, Sorbel J, Norton JA Jr, et al. (1996) Motor changes in presymptomatic Huntington disease gene carriers. Arch Neurol 53: 487-492.
14. Smith MA, Brandt J, Shadmehr R (2000) Motor disorder in Huntington's disease begins as a dysfunction in error feedback control. Nature 403: 544-549.
15. Feigin A, Ghilardi MF, Huang C, Ma Y, Carbon M, et al. (2006) Preclinical Huntington's disease: compensatory brain responses during learning. Ann Neurol 59: 53-59.
16. de Boo GM, Tibben A, Lanser JB, Jennekens-Schinkel A, Hermans J, et al. (1997) Early cognitive and motor symptoms in identified carriers of the gene for Huntington disease. Arch Neurol 54: 1353-1357.
17. Robins Wahlin TB, Lundin A, Dear K (2007) Early cognitive deficits in Swedish gene carriers of Huntington's disease. Neuropsychology 21: 31-44.
18. Verny C, Allain P, Prudean A, Malinge MC, Gohier B, et al. (2007) Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene. Eur J Neurol 14: 1344-1350.
19. Farrow M, Chua P, Churchyard A, Bradshaw JL, Chiu E, et al. (2006) Proximity to clinical onset influences motor and cognitive performance in presymptomatic Huntington disease gene carriers. Cogn Behav Neurol 19: 208-216.
20. Larsson M, Lundin A, Robins Wahlin TB (2006) Olfactory functions in asymptomatic carriers of the Huntington disease mutation. J Clin Exp Neuropsychol 28: 1373-1380.
21. Globas C, du Montcel ST, Baliko L, Boesch S, Depondt C, et al. (2008) Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6. Mov Disord 23: 2232-2238.
22. Rosa AL, Molina I, Kowaljow V, Conde CB (2006) Brisk deep-tendon reflexes as a distinctive phenotype in an Argentinean spinocerebellar ataxia type 2 pedigree. Mov Disord 21: 66-68.
23. Velazquez Perez L, Sanchez Cruz G, Canales Ochoa N, Rodriguez Labrada R, Rodriguez Diaz J, et al. (2007) Electrophysiological features in patients and presymptomatic relatives with spinocerebellar ataxia type 2. J Neurol Sci 263: 158-164.
24. Fernandez-Ruiz J, Velasquez-Perez L, Diaz R, Drucker-Colin R, Perez-Gonzalez R, et al. (2007) Prism adaptation in spinocerebellar ataxia type 2. Neuropsychologia 45: 2692-2698.
25. Martin TA, Keating JG, Goodkin HP, Bastian AJ, Thach WT (1996) Throwing while looking through prisms. I. Focal olivocerebellar lesions impair adaptation. Brain 119 (Pt 4): 1183-1198.
26. Denny-Brown D, David MD, Tyler HR (1982) Handbook of neurological examination and case recording. Harvard University Press.
27. Schmitz-Hubsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, et al. (2006) Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66: 1717-1720.
28. Fernandez-Ruiz J, Diaz R (1999) Prism adaptation and aftereffect: specifying the properties of a procedural memory system. Learn Mem 6: 47-53.
29. Inagaki A, Iida A, Matsubara M, Inagaki H (2005) Positron emission tomography and magnetic resonance imaging in spinocerebellar ataxia type 2: a study of symptomatic and asymptomatic individuals. Eur J Neurol 12: 725-728.
30. Wolf RC, Vasic N, Schonfeldt-Lecuona C, Landwehrmeyer GB, Ecker D (2007) Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. Brain 130: 2845-2857.